Covid-19 roundup: EMA of­fi­cial says 'clear' link be­tween As­traZeneca shot and blood clots — re­port; No­vavax al­lows place­bo group to get vac­cine

For the first time Tues­day, health of­fi­cials ac­knowl­edged a link be­tween the As­traZeneca/Ox­ford Uni­ver­si­ty Covid-19 vac­cine and blood clots fol­low­ing a tense few weeks of coun­tries across Eu­rope sus­pend­ing use of the shot.

A top vac­cine ex­pert at the EMA said in an in­ter­view with Ital­ian news­pa­per Il Mes­sag­gero that there is a con­nec­tion be­tween the vac­cines and throm­bot­ic events, but the caus­es re­main un­known. The in­di­vid­ual ap­peared to dis­close the in­for­ma­tion sep­a­rate­ly from an of­fi­cial EMA an­nounce­ment but not­ed that the agency would do so lat­er Tues­day and pro­vide up­dat­ed guide­lines on the shot Wednes­day, ac­cord­ing to The Guardian.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.